New Delhi, March 24 To ensure ethical pharmaceutical practices in the supply chain of weight-loss drugs of the GLP-1 class, the Drugs Controller General of India (DCGI) has intensified its regulatory surveillance against the unauthorized sale and promotion of the medications.To this end...
New Delhi, March 17 – The Delhi High Court issued a notice on Tuesday regarding a contempt petition alleging non-compliance with its earlier order directing the Central Drugs Standard Control Organisation (CDSCO) to examine safety and regulatory concerns regarding the use of certain diabetes...
cdsco
central drugs standard control organisation
contempt petition
dcgi
delhi high court
diabetes drugs
drugs controller general of india
glp-1 receptor agonists
judicial directions
legal proceedings
new drugs and clinical trials rules
pharmacovigilance
regulatory compliance
union health secretary
weight loss